Atossa Genetics Shares Jump Following Deal with FedMed

Atossa Genetics, Inc.

, The Breast Health Company(TM), has entered into a contractual agreement with FedMed, Inc., one of the largest proprietary Preferred Provider Organization (PPO) networks in the U.S., for diagnostic laboratory testing. FedMed's network is comprised of more than 550,000 providers, including 4,000 hospitals and more than 60,000 ancillary facilities, serving over 40 million Americans. Atossa's agreement with FedMed will give FedMed's participating providers and its clients' members greater access to Atossa's tests, including the ForeCYTE Breast Health Test and the ArgusCYTE Breast Health Test. The stock is up more than 22 percent at last check.